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Posttranslational modifications of proteins play key roles in the regulation of biological processes and lead to
various physiological responses. In recent years, a number of analytical technologies have been developed
to help understand the diversity and disease relevance of these modifications. The main areas of focus have
included phosphorylation, cysteine redox chemistry, and transformations mediated directly by oxidative
stress. However, the nitration of biomolecules is an exciting and relatively understudied area of research.
Reactive nitrogen species generated in various disease states can create nitrated biomolecules, and we
are only beginning to understand the potential implications of these species. This review explores some of
the recent advances in current knowledge concerning the chemistry and biology of nitrated biomolecules.Reactive Nitrogen Species and Nitrative Stress
Reactive nitrogen species (RNS) are formed in various inflamma-
tory disease states and include molecules such as nitric oxide
(NO), nitrogen dioxide (NO2) and dinitrogen trioxide (N2O3).
One of the most important species involved in the nitration of
biomolecules is peroxynitrite (ONOO), which is a powerful
nitrating agent formed primarily through the reaction of super-
oxide (O2
$) with NO, itself produced through inducible nitric
oxide synthase (iNOS) in activated macrophages (Figure 1)
(Pacher et al., 2007; Szabo´ et al., 2007). Peroxynitrite is also
a powerful oxidant, and indeed oxidation may dominate over
nitration chemistry depending on context and microenviron-
ment. The steady-state concentration of peroxynitrite has been
estimated to be in the nanomolar range due to its reaction with
various biomolecules (Nalwaya and Deen, 2005; Quijano et al.,
2005), but the rate of production in vivo could be as high as
100 mM/min (Alvarez et al., 2004). Peroxynitrite can also rapidly
react with carbon dioxide ([CO2] in equilibrium with bicarbonate)
to produce the carbonate radical anion (CO3
$) and NO2, via the
short-lived species nitrosoperoxycarbonate (ONOOCO2
) (Gow
et al., 1996; Marla et al., 1997), also leading to biomolecule nitra-
tion (discussed later). NO2 can undergo a further reaction with
NO to create N2O3, a powerful nitrosating agent of biomolecules
(Dedon and Tannenbaum, 2004; Hughes et al., 1958).
The nitration of lipids, proteins, and oligonucleotides causes
profound effects on the biochemistry of these biomolecules,
and this review highlights recent advances in the understanding
of the roles these species play in biology and disease.
Nitrated Proteins
Protein tyrosine nitration (PTN) is a posttranslational modification
typically resulting from either the peroxynitrite-mediated nitra-
tion of the 3-position of the phenol group in tyrosine under the
nitrative stress conditions of disease or the actions of heme
peroxidases on nitrite (NO2
) to form NO2 that can also nitrate
tyrosine residues (Eiserich et al., 1998; van der Vliet et al.,
1997). Another mechanism involves the reaction of CO3
$ (Fig-
ure 1) with tyrosine to form the phenoxy radical intermediate
that subsequently reacts with NO2 to form nitrated tyrosine (Gu-
naydin and Houk, 2009). Indeed, the presence of 3-nitrotyrosine
(3-NT) is often used as a biomarker for inflammation-associated1086 Chemistry & Biology 19, September 21, 2012 ª2012 Elsevier Ltconditions and is a hallmark of various diseases (Aoyama et al.,
2000; Aulak et al., 2004; Basso et al., 2009; Drel et al., 2010; Jin
et al., 2011; MacMillan-Crow et al., 1996; Montoliu et al., 2011;
Nakamura et al., 2006; Pacher et al., 2007; Radi, 2004; Shisheh-
bor et al., 2003; Winyard et al., 2011). The highly electron-with-
drawing nature of the nitro group substantially increases the
acidity of the phenol moiety—for example, pKa 10.1 (tyrosine);
pKa 7.2 (3-NT)—and this feature was recently harnessed as
a probe through site-specific incorporation of 3-NT to perturb
the pKa of redox-active tyrosines in ribonucleotide reductase
(Yokoyama et al., 2010). The change in acidity, as well as the
steric crowding of the aromatic hydroxyl group, has also been
shown to significantly reduce protein phosphorylation by tyro-
sine kinases (Monteiro et al., 2008). However, there was a report
of a nitrotyrosine residue acting as a phosphotyrosine mimetic
and activating the Src family kinase Lyn (Mallozzi et al., 2001).
Steric inactivation of enzyme function has also been shown
for manganese superoxide dismutase (MnSOD), resulting from
the nitro group of an active site nitrotyrosine blocking the
entrance of O2
$, while the nitration of surface tyrosine residues
did not affect enzyme activity (Figure 2A) (MacMillan-Crow
et al., 1996; Quint et al., 2006; Surmeli et al., 2010). In an elegant
study, site-specific nitration of Tyr-34 in MnSOD using genetic
encoding of the 3-NT residue completely ablated protein func-
tion, thus categorically confirming the essential nature of this
specific residue (Neumann et al., 2008). Reducing the activity
of MnSOD of course increases the concentration of O2
$, and
subsequently peroxynitrite, thus amplifying nitrative and oxida-
tive stress pathways.
Since it is a stable proteinmodification, several strategies have
been developed to measure the nitrated proteome (nitrome) in
biological samples directly (Abello et al., 2009). For example,
anti-3-nitrotyrosine antibodies have been developed to enable
the immunoprecipitation of nitrated proteins, which can be
subsequently analyzed and characterized using sophisticated
mass spectrometry proteomic techniques (D’Alessandro et al.,
2011). Alternatively, since PTN is such a low-abundance modifi-
cation (reaching just five 3-NT residues per 10,000 Tyr residues
under inflammatory conditions) (Radi, 2004), sophisticated
technologies have been developed to enrich the nitrome from
pathophysiologic samples. For example, a recent method usedd All rights reserved
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Figure 1. Reactive Nitrogen Species
A major pathway that generates RNS in vivo is illustrated.
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Reviewthe hydrosulfite reduction of the nitro group to the aniline, which
was subsequently tagged with a perfluorinated aliphatic linker
that allowed protein enrichment using solid fluorous phase
technology (fluorinated carbon-linked silica beads) (Kim et al.,
2011). However, there is need for caution in the interpretation
of proteomic data in this area due to high false-positive rates,
highlighting the need for manual validation criteria and peptide
synthesis to confirm and characterize nitrated protein hits (Pro-
kai, 2009; Stevens et al., 2008).
Nevertheless, these technical advances have furthered our
understanding of how nitrated proteins are implicated in a variety
of diseases, including neurodegeneration, inflammation, and
cancer. A number of recent examples are highlighted here that
illustrate the fascinating biochemistry and disease relevance of
PTN chemistry.
Nitroaromatics are well-known immunogenic epitopes, and
the nitration of tyrosine residues on proteins is known to trigger
autoimmune T cell responses that can break self-tolerance (Birn-
boim et al., 2003; Hardy et al., 2008; Herzog et al., 2005; Nagaraj
et al., 2007; Ohmori and Kanayama, 2005). At a molecular level,
the X-ray crystal structure of wild-type and nitrated peptide
epitopes (lymphocytic choriomeningitis virus-associated immu-
nodominant epitope gp34) with the major histocompatibility
complex H-2Kb confirms significant destabilizing effects through
conformational strain on the complex as a result of nitration
(Figure 2B) (Madhurantakam et al., 2012). This may explain the
effects of PTN on T cell receptor recognition and provide insights
into the molecular basis for nitrotyrosine neoantigen formation
and evasion of immunotoleration.
Similarly, immunization of mice with a 3-NT TNF-a elicits
antibodies to the native, unaltered protein (Gauba et al., 2011).
CD4 T cell recognition is necessary for autoantibody production,
and activation results from the presentation of the nitrotyrosine
neoepitope. These studies suggest the involvement of nitrated
tyrosines in antibody-mediated autoimmune disorders, and
a recent report highlights the potential involvement of nitrated
type-II collagen in rheumatoid arthritis (Winyard et al., 2011).
PTN may also play a factor in the undesired modification of
protein therapeutics. Mass spectrometry (nano-LC-ESI-MS/
MS; LTQ Orbitrap) was used recently to identify nitrated tyro-
sines in the neutralizing vascular endothelial growth factor
antibody drug bevacizumab (Avastin) (Wan et al., 2012). These
observations suggest that the analysis of therapeutic proteins
should be made early in the drug development process to
understand immunogenic potential from nitrated tyrosines.
a-Synuclein is a natively unfolded, neuronal protein linked to
the neuropathogenesis of Parkinson’s disease (PD) through the
formation of fibrillar, misfolded protein aggregates called Lewy
bodies (Stefanis, 2012). Tyrosine nitration of a-synuclein is
believed to enhance aggregation potential and promote fibrilChemistry & Biology 1formation (Giasson et al., 2000), although it remains to be fully
elucidated if this plays a causative role in PD or is merely a
biomarker of the disease. A novel mechanism explaining the
toxicity of nitrated a-synuclein has been proposed recently that
describes the binding of the nitrated protein to integrin a5b1, re-
sulting in the inhibition of FAK phosphorylation, so increasing
caspase 3 activity that causes cell apoptosis (Liu et al., 2011).
It is interesting that another study showed that peroxynitrite-
mediated nitration of all four available tyrosine residues in re-
combinant a-synuclein produced an immunogen that could
break self-tolerance in mice (Benner et al., 2008). The induc-
tion of the adaptive immune response in this way points to
a mechanism that exacerbates the pathology of PD through
the degeneration of nigral dopaminergic neurons. Harnessing
this immunological response through the creation of nitrated
misfolded protein immunogens that shift the balance between
effector and regulatory T cell responses may enable the creation
of novel therapeutic strategies for PD (Ha et al., 2012).
Neuroinflammation is also known to cause the nitration of tau
protein through the actions of peroxynitrite, which is believed to
have implications in the pathogenesis of Alzheimer’s disease
(Kummer et al., 2011; Reyes et al., 2011). However, through
the creation of a mutant tau that lacks all tyrosines, it was
recently shown that peroxynitrite can cause additional modifica-
tions, including lysine formylation, thus highlighting the nonspe-
cific nature of peroxynitrite chemistry (Vana et al., 2011).
Another illustrative example describes the tyrosine nitration of
cytochrome c resulting in a switch from the electron-transfer
function to cardiolipin peroxidation. Resonance Raman and
electrochemical techniques were used to probe this transition
on a specially created mutant of cytochrome c, where four of
the five tyrosine residues were replaced with phenylalanine, al-
lowing the remaining tyrosine to be nitrated with peroxynitrite
(Ly et al., 2012). This work suggests that the switch to peroxidase
activity upon tyrosine nitration is a result of a strongly negatively
shifted redox state and increased accessibility of hydrogen
peroxide resulting from destabilization of the heme pocket.
PTN has also been implicated in the pathophysiology of
cancer due to the increased concentrations of RNS in the micro-
environment of the tumor (Pacher et al., 2007). For example,
nitration of Tyr 327 in p53 (observed in human gliomas) promotes
p53 oligomerization, nuclear accumulation, and activation
(Cobbs et al., 2001; Yakovlev et al., 2010). Another example is
the observation that high PTN levels are observed in the
antigen-specific tumor-infiltrating lymphocytes (TILs) of human
prostatic adenocarcinomas, which exerts an immunosuppres-
sive action in situ (Bronte et al., 2005). Tumor responsiveness
was restored when arginase and nitric oxide synthase (NOS)
(that are overexpressed in malignancies and the cause of high
peroxynitrite levels) were inhibited, thus reducing RNS and
nitrative stress. Additionally, RNS in the tumor can nitrate the
CCL2 chemokine and reduce access of TILs to the inner core
of the tumor (Molon et al., 2011).
Tryptophan is another amino acid that is nitrated under condi-
tions of nitrative stress and these nitrotryptophan species may
also play a key role in cellular processes (Nuriel et al., 2011).
Unlike tyrosine that is nitrated at a single site, tryptophan can
be nitrated at all six available positions of the aromatic ring,
thus complicating analysis and characterization of specific9, September 21, 2012 ª2012 Elsevier Ltd All rights reserved 1087
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Figure 2. Examples of Protein Tyrosine Nitration
(A) Crystal structure of nitrated MnSOD showing steric congestion of manganese ion (PDB code 2ADP).
(B) Crystal structure of gp34 in complex with H-2Kb (PDB code 3ROL). Arrows highlight 3-NT residues.
(C) Crystal structure of GAPDH with NAD+ (magenta) (PDB code 1ZNQ). Reactive tyrosine and cysteine residues are highlighted.
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nitrotryptophan, as described earlier for nitrotyrosine, will be
required to shed new insights into the biology and disease
relevance of this transformation. For example, a recent mass
spectrometry proteomic analysis of rat brain was performed
using an anti-6-nitrotryptophan-specific antibody for western
blot analysis (Uda et al., 2012). Increased levels of NOS in the
cerebellum relative to the hippocampus were mirrored in the
total amounts of 6-nitrotryptophan-containing proteins in these
two regions of the brain.
Nitrated Lipids
The hydrophobic environment of biological membranes can
significantly increase the local concentrations of nitrative and
oxidative species such as NO, that can facilitate the chemical
modification of lipids, creating the so-called ‘‘molecular lens’’
effect (Freeman et al., 2008; Kalyanaraman, 2004). Multiple
reactions can lead to the generation of nitrated lipids, including
a mechanism that proceeds through the oxidation of NO with
oxygen to form NO2 that directly attacks the olefin double
bond in unsaturated fatty acids. The addition of the electron-
withdrawing nitro group converts the olefin into a highly reactive
electrophile that can undergo rapid physiologically relevant
Michael additions with nucleophiles such as glutathione and
cysteine-containing proteins (Batthyany et al., 2006). It is unsur-
prising that this motif is significantly more reactive than other
endogenous electrophiles such as 4-hydroxynonenal (Baker
et al., 2007).
One of the most studied nitrated lipids is nitrooleic acid (NOA)
(Figure 3), since oleic acid is the most abundant monounsatu-
rated fatty acids in human plasma. Although the basal plasma
concentration of NOA (9- and 10-NOA isomers, specifically) is
low (approximately 1 nM as determined by gas chromatography
coupled with tandem mass spectrometry, using 15N-labeled
NOAs as standards) (Tsikas et al., 2011), the likely local con-
centration in cell membranes (particularly in disease states) is
much higher, and when the reactive nature of the electrophile
is considered, it suggests that the membrane chemistry of
nitrated lipids is highly relevant to signaling processes. Equally,
the total concentrations of NOA esters and other related metab-
olites remain to be elucidated. Complications in analysis
also arise due to the decomposition of nitrolipids to yield NO
via a Nef-like reaction in aqueous environments, although this
is inhibited when the electrophile partitions into hydrophobic
membranes (Rudolph et al., 2009).1088 Chemistry & Biology 19, September 21, 2012 ª2012 Elsevier LtThe reactome of NOA has been partially studied, and these
chemistries result in a variety of biological effects. For example,
NOA reacts with the cysteine-rich TrpA1 and TrpV1 ion channels
in dorsal root ganglion neurons, causing membrane depolariza-
tion and inward currents (Sculptoreanu et al., 2010; Taylor-Clark
et al., 2009). Initial activation of the Trp channels may propagate
inflammatory responses, but prolonged exposure with NOAmay
indeed desensitize these channels, thus controlling the duration
and magnitude of the inflammatory response.
NOA and the related nitrolinoleic acid (NLA) (Figure 3) were
shown to inactivate glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) through covalent addition to the active site
Cys-149 (Batthyany et al., 2006). Noticeably, tyrosine nitration
of GAPDH is also well documented in a variety of inflammatory
diseases and occurs at positions Tyr-311 and Tyr-317, resulting
in the inactivation of the enzyme by preventing the binding of the
cofactor nicotinamide adenine dinucleotide (NAD+) (Palamalai
and Miyagi, 2010), and these residues are in close proximity to
Cys-149 (Figure 2C).
NOA and NLA have also been found to react with the p65
subunit of nuclear factor-kappa B (NF-kB), thus preventing
DNA binding, resulting in repressed gene expression, so sug-
gesting an anti-inflammatory effect of these molecules (Cui
et al., 2006). Similarly, nitrated lipids have been shown to irre-
versibly inactivate the proinflammatory xanthine oxidoreductase
protein (Kelley et al., 2008) and activate the nuclear factor
erythroid 2-related factor 2 (NRF-2) pathway (and the antioxidant
response element [ARE]) through reaction with the cysteine-rich
protein kelch-like ECH-associated protein (KEAP-1) (Kansanen
et al., 2011; Villacorta et al., 2007).
Nitrated fatty acids are also partial agonists of peroxisome
proliferator-activated receptor-gamma (PPARg) that covalently
add to the Cys-285 residue causing receptor conformational
changes. The resulting selective modulation of coregulator pro-
tein interactions led to the expression of key target genes and
subsequent administration of NOA to diabetic mice resulted in
a reduction in insulin and glucose levels without undesired side
effects (Schopfer et al., 2010).
A significant advance in this area has been realized through
the selective syntheses of nitrolipids. For example, a nitroselene-
nylation/oxidation route to 9- and 10-NLA enabled comparative
studies of the aqueous stability of these species (Manini et al.,
2008). It is interesting that the remarkably different chemical
stabilities of isomeric NLAs under physiologically relevant con-
ditions may explain why 10-NLA, but not 9-NLA, has beend All rights reserved
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Figure 3. Some Products of Nitrative Stress
Arrows indicate sites of nucleophilic Michael addition.
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prepared in a regio- and stereocontrolled manner via a nitro aldol
reaction to form the key C9-C10 linkage (Dunny and Evans, 2010).
The pure 10-NLA isomer was then confirmed as a potent binder
of PPAR-g.
Nitrated Oligonucleotides
DNA damage in inflammatory conditions is believed to play
a major role in the pathophysiology of disease and, in particular,
cancer. One molecular mechanism that is believed to cause
these effects is the reaction between RNS and DNA, which can
lead to a plethora of oxidized, nitrated, and deaminated products
(DeMott and Dedon, 2010). Of particular relevance to this review
is the reaction of ONOO with deoxyguanosine to release
8-nitroguanine (Figure 3) and apurinic sites in DNA, leading to
lesions and carcinogenesis. Indeed, anti-8-nitroguanine anti-
bodies can be used immunohistochemically to evaluate the
risk of inflammation-associated carcinogenesis, and the forma-
tion of 8-nitroguanine was significantly associated with tumor
invasion and poor prognosis of cancer patients (Hiraku and
Kawanishi, 2009).
Similarly, 8-nitroguanosine (Figure 3) is a known product of
RNA nitration by ONOO and has been observed in a mouse
model of viral pneumonia (Akaike et al., 2003). Additionally,
8-nitroguanosine was found to stimulate O2
$ generation from
cytochrome P450 reductase and iNOS in the same study, sug-
gesting a potential role in the pathogenesis of the disease.
Other Secondary Targets
Additional secondary targets of nitration include the catechol-
amines, producing molecules such as 6-nitrodopamine
(Figure 3), 6-nitroepinephrin, and various oligomeric species
(d’Ischia et al., 2011). These species have been identified in
mammalian brain and may be components of pathophysiolog-Chemistry & Biology 1ical neuronal damage, although further studies are required to
confirm this.
Other nitrated molecules include the retinoic acids and estra-
diols. Additional targets include a variety of drugs and other
xenobiotics, and the roles these species play in disease have
been reviewed recently (d’Ischia et al., 2011).
Future Work
Biomolecule nitration is a fascinating area of research, and
further insights into the disease relevance of these species
remains a significant challenge for the scientific community,
primarily due to the lack of enabling technologies that allow us
to put these transformations into physiologic context. As a result,
there exist significant opportunities for chemical biology to
improve the toolbox for studying RNS. For example, through
the application of chemoproteomic techniques and activity-
based proteomic profiling (Moellering and Cravatt, 2012), cell-
permeable nitrolipid probes could be developed to report on
biomolecular reactions in an unbiased sense in vivo. These
methods would also drive a deeper understanding of the
lipidome (Quehenberger and Dennis, 2011). Additionally, the
growing knowledge of tyrosine nitration and immunogenicity
will enable structure–activity relationships to be delineated that
can be harnessed in the creation of new synthetic vaccines or
to engineer safer protein therapeutics. Nitration biochemistry
has significant implications for drug molecules, since a small
molecule may trigger RNS generation through redox cycling or
indirectly increase RNS leading to toxicological outcomes. For
example, cisplatin-induced ototoxicity was recently shown to
be mediated via NOX3 activation, leading to increases in O2
$
production, causing tyrosine nitration of the cochlear protein
Lmo4 (Jamesdaniel et al., 2012). In drug design, researchers
could elucidate the propensity for tyrosine residues to react
with electrophilic species and then harness this to deliberately
target the covalent inactivation of specific proteins, similar to
the cysteine targeting of kinases.
There is, of course, significant promise for anti-inflammatory
drugs that can reduce RNS for a number of diseases and where
the effectiveness of treatments can be assessed using PTNs or
3-NT as biomarkers. Opportunities also exist for repurposing
existing drugs or molecules in clinical development that can
modulate nitration signatures of disease. For example, PPAR-g
agonists can reverse the tyrosine nitration of sarcoplasmic
endoplasmic reticulum Ca2+-ATPase found in the platelets of
Type 2 diabetes mellitus patients, so normalizing calcium
homeostasis and highlighting potential benefits for cardiovas-
cular diseases (Randriamboavonjy et al., 2008).
Alternatively, drugs that trigger nitration may have therapeutic
benefit also. For example, simvastatin was used to increase
the cytotoxicity of doxorubicin in human colon cancer cells by
upregulating NF-kB, increasing NO and nitrative stress (Riganti
et al., 2008). This caused tyrosine nitration of multidrug resis-
tance-related protein 3, so increasing the intracellular concen-
trations of doxorubicin.
Future endeavors in this area could focus on furthering our
understanding of nitration biochemistry of protein misfolding,
epigenetic regulation and autoimmunity in particular. Beyond
RNS and ROS, further advances are yet to be made in our
understanding of the roles of reactive halogen and carbon9, September 21, 2012 ª2012 Elsevier Ltd All rights reserved 1089
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Reviewspecies, and chemical biology will continue to play a key role in
furthering our knowledge of pathological chemistry.
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